John G. Moffat

ScholarGPS® ID: 91589800487272

Affiliation History

Metrics Summary
Publication Count
34
Predicted Citations
4,131
Predicted h-index
22
Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

You must register and claim your profile to add or remove publications from it.
... publications
FILTER BY:
Year
Type
Specialty
Affiliations
Collaborations
Access
Country/Region
Co-Authors
Delete
Anderson, Jake W | Vaisar, David | Jones, David N | Pegram, Laurel M | Vigers, Guy P | Chen, Huifen | Moffat, John G | Ahn, Natalie G
eLife, volume 12 (2024).
Anderson, Jake W | Vaisar, David | Jones, David N | Pegram, Laurel M | Vigers, Guy P | Chen, Huifen | Moffat, John G | Ahn, Natalie G
eLife, volume 12 (2024).
Ma, Hsiao-Yen | Vander Heiden, Jason A. | Uttarwar, Salil | Xi, Ying | N'Diaye, Elsa-Noah | LaCanna, Ryan | Caplazi, Patrick | Gierke, Sarah | Moffat, John | Wolters, Paul J. | Ding, Ning
European Respiratory Journal, volume 61, issue 4, pages 2200604- (2023).
Journal of Medicinal Chemistry, volume 65, issue 17, pages 11500-11512 (2022).
Discovery and Development of GDC-0994: A Selective and Efficacious Small Molecule Inhibitor of ERK1/2 (book chapter)
In Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 1
American Chemical Society (2018)
Nature Reviews Drug Discovery, volume 16, issue 8, pages 531-543 (2017).
Cell Chemical Biology, volume 24, issue 5, pages 545-547 (2017).